Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Litani Ventures is a private investment firm and family office associated with entrepreneur Peter Rahal, founder of RXBAR. The firm is based in Chicago and appears to invest primarily in early-stage and growth companies across consumer, food, sustainability, software, and selected biotechnology or healthcare-related opportunities. Available public sources describe it as an active investor rather than an operating biotech, pharma, or healthcare company. It does not appear to develop its own therapeutic products, clinical pipeline, or drug-discovery platform. For biotech analyst purposes, Litani Ventures is best classified as a financial sponsor with occasional exposure to life science investments rather than a life sciences operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Litani Ventures.